AMC three-lens brief
Evidence-based stock research on AMC. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Outperforming SPY by 20.9pp over 30 days. · Trading at 12% of its 52-week range — deep in the lower band.
- Trading at 12% of its 52-week range — deep in the lower band.
- Outperforming SPY by 20.9pp over 30 days.
- Currently unprofitable on a trailing basis — no P/E multiple available.
- Analyst mean target $2.03 — 55% above current (6 analysts).
- Reported earnings on 2026-05-06.
AMC closed at $1.32 (-1.82%) as of 2026-05-13. Market cap: $975.85M. Positives: outperforming SPY by 20.9pp over 30 days.; analyst mean target $2.03 — 55% above current (6 analysts).. Concerns: trading at 12% of its 52-week range — deep in the lower band.; currently unprofitable on a trailing basis — no P/E multiple available.. Last quarter: Revenue $1.05B, net income -$117.10M, free cash flow $90.09M.
Why three lenses on AMC, not one.
A single reasoning model has blind spots it doesn’t know about. We examine AMCacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/AMC" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath AMC brief"></iframe>